US Development Financing Needs to Stop Rewarding Nations Whose Policies Harm US Companies and Workers
The U.S. Development Finance Corporation (DFC), which was created to serve counterweight to China’s Belt-and-Road initiative, rewards countries whose intellectual property and data policies harm American commercial interests and jobs. That needs to stop.
How Experts in China and the United Kingdom View AI Risks and Collaboration
As AI continues to advance, the technology has created many opportunities and risks. Despite significant geopolitical differences, a series of interviews with AI experts in China and the United Kingdom reveals common AI safety priorities, shared understanding of the benefits and risks of open source AI, and agreement on the merits of closer collaboration—but also obstacles to closer partnerships.
How Innovative Is China in Biotechnology?
China used to be considered a laggard in biotech. But with a comprehensive national strategy and extensive resources now supporting the industry, it is becoming more innovative. In fact, several indicators suggest it is narrowing the innovation gap with global leaders in the West.
From Cart to Claim: Addressing Product Liability in Online Marketplaces
State product liability laws traditionally hold manufacturers, distributors, and sellers strictly liable for defective products they bring to market. As consumers increasingly make purchases from online marketplaces—platforms that aggregate products from multiple third-party sellers—new questions arise about how to best protect them from defective products that pose a risk to health and safety.
Assessing Canadian Innovation, Productivity, and Competitiveness
Canada faces unprecedented challenges in innovation, productivity, and competitiveness. The first step in addressing them is to develop a clear understanding of the Canadian economy’s underlying structure and performance in each area. Policymakers must then tailor strategies for specific industries and technologies instead of focusing on principally on macro factors.
Not Again: Why the United States Can’t Afford to Lose Its Biopharma Industry
America’s leadership in advanced-technology industries can never be taken for granted, as evidenced by its losses in telecommunications equipment, semiconductors, televisions, solar panels, and chemicals. Policymakers must recognize what went wrong in those cases to avoid a similar industrial decline in the biopharmaceutical industry.
The Hamilton Index, 2023: China Is Running Away With Strategic Industries
China now dominates the strategically important industries in ITIF’s Hamilton Index, producing more than any other nation in absolute terms and more than all but a few others in relative terms. Its gains are coming at the expense of the United States and other G7 and OECD economies, and time is running short for policymakers to mount an industrial comeback.
